These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11563298)

  • 21. Monitoring intravascular volumes to direct hypertensive, hypervolemic therapy in a patient with vasospasm.
    Segal E; Greenlee JD; Hata SJ; Perel A
    J Neurosurg Anesthesiol; 2004 Oct; 16(4):296-8. PubMed ID: 15557835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intensive care using hypervolemic hypertensive hemodilution in the acute period of subarachnoidal hemorrhages in patients with arterial aneurysms].
    Kurdiumova NV; Parfenov AL; Fokin MS; Grinenko EA; Eliava ShSh; Kheĭreddin AS; Sazonov IA
    Zh Vopr Neirokhir Im N N Burdenko; 2006; (2):48-53. PubMed ID: 16827430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage.
    Miller JA; Dacey RG; Diringer MN
    Stroke; 1995 Dec; 26(12):2260-6. PubMed ID: 7491647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?
    Zemke D; Farooq MU; Mohammed Yahia A; Majid A
    Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Systemic treatments of the vasospasm].
    Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative hypertensive-hypervolaemic-haemodilution (Triple H) therapy in the treatment of vasospasm following aneurysmal subarachnoid haemorrhage.
    Gupta D; Sharma BS; Gupta SK; Bapuraj R; Khosla VK
    Neurol India; 2000 Jun; 48(2):126-31. PubMed ID: 10878775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
    Sakowitz OW; Unterberg AW
    Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension.
    Awad IA; Carter LP; Spetzler RF; Medina M; Williams FC
    Stroke; 1987; 18(2):365-72. PubMed ID: 3564092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of triple H therapy in a patient with an ischemic penumbra following subarachnoid hemorrhage: a case study.
    Ogungbo B; Prakash S; Ushewokunze S; Etherson K; Sinar J
    J Neurosci Nurs; 2005 Dec; 37(6):326-8, 333. PubMed ID: 16396086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New concepts regarding cerebral vasospasm: glial-centric mechanisms.
    Mutch WA
    Can J Anaesth; 2010 May; 57(5):479-89. PubMed ID: 20131107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study.
    Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
    Neurosurgery; 2001 Sep; 49(3):593-605; discussion 605-6. PubMed ID: 11523669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are We Barking Up the Wrong Vessels? Cerebral Microcirculation After Subarachnoid Hemorrhage.
    Terpolilli NA; Brem C; Bühler D; Plesnila N
    Stroke; 2015 Oct; 46(10):3014-9. PubMed ID: 26152299
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy.
    Hoh BL; Carter BS; Ogilvy CS
    Neurosurgery; 2002 Jun; 50(6):1207-11; discussion 1211-2. PubMed ID: 12015837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage.
    Raabe A; Beck J; Keller M; Vatter H; Zimmermann M; Seifert V
    J Neurosurg; 2005 Dec; 103(6):974-81. PubMed ID: 16381183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The quantitative time-resolved near infrared spectroscopy (TR-NIRs) for bedside cerebrohemodynamic monitoring after aneurysmal subarachnoid hemorrhage: can we predict delayed neurological deficits?
    Poon WS; Wong GK; Ng SC
    World Neurosurg; 2010 May; 73(5):465-6. PubMed ID: 20920925
    [No Abstract]   [Full Text] [Related]  

  • 36. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage.
    Qureshi AI; Suarez JI; Bhardwaj A; Yahia AM; Tamargo RJ; Ulatowski JA
    Crit Care Med; 2000 Mar; 28(3):824-9. PubMed ID: 10752836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic monitoring in the care of the critically ill neuroscience patient.
    Blissitt PA
    AACN Adv Crit Care; 2006; 17(3):327-40. PubMed ID: 16931928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic approaches to vasospasm in subarachnoid hemorrhage.
    Dorsch NW
    Curr Opin Crit Care; 2002 Apr; 8(2):128-33. PubMed ID: 12386513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypervolemic and hypertensive therapy in the treatment of ischemic disorders following subarachnoid hemorrhage].
    Pasqualin A; Da Pian R; Scienza R; Formenton A
    Minerva Anestesiol; 1982 Oct; 48(10):683-5. PubMed ID: 7145120
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Unterberg AW; Sakowitz OW; Sarrafzadeh AS; Benndorf G; Lanksch WR
    J Neurosurg; 2001 May; 94(5):740-9. PubMed ID: 11354405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.